mTOR as a central regulator of lifespan and aging
David Papadopoli(Jewish General Hospital), Karine Boulay(Jewish General Hospital), Lawrence Kazak(Occupational Cancer Research Centre), Michaël Pollak(Jewish General Hospital), Frédérick A. Mallette(Hôpital Maisonneuve-Rosemont), Ivan Topisirović(Jewish General Hospital), Laura Hulea(Hôpital Maisonneuve-Rosemont)
Cited by 434Open Access
Abstract
The mammalian/mechanistic target of rapamycin (mTOR) is a key component of cellular metabolism that integrates nutrient sensing with cellular processes that fuel cell growth and proliferation. Although the involvement of the mTOR pathway in regulating life span and aging has been studied extensively in the last decade, the underpinning mechanisms remain elusive. In this review, we highlight the emerging insights that link mTOR to various processes related to aging, such as nutrient sensing, maintenance of proteostasis, autophagy, mitochondrial dysfunction, cellular senescence, and decline in stem cell function.
Related Papers
No related papers found
Powered by citation graph analysis